RET-IN-1
CAS No. 2222755-14-6
RET-IN-1( —— )
Catalog No. M21830 CAS No. 2222755-14-6
RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1503 | Get Quote |
|
| 50MG | 3042 | Get Quote |
|
| 100MG | 4140 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRET-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionRET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552.
-
DescriptionRET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552, has IC50s of 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2222755-14-6
-
Formula Weight553.255
-
Molecular FormulaC29H31N9O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN#CC1=C2C(C3=NC=C(N4CC(C5)N(CC6=CC=C(OC)N=C6)C5C4)N=C3)=CC(OC[C@H]7CNCCO7)=CN2N=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ganglioside GM1
Ganglioside GM1 is one of the major sphingolipids (GSLs) on the cell surface of the central nervous system (CNS), which is protective of the CNS and is used in the study of neurological disorders.
-
Gallic acid trimethy...
Used as a medicine, organic synthesis intermediates.
-
Anti-inflammatory ag...
Anti-inflammatory agent 35 is a potent anti-inflammatory agent.
Cart
sales@molnova.com